Joseph Kilianski1, Sophie Peeters1, Jeff Debad2, Joseph Mohmed3, Steven E Wolf3, Joseph P Minei3, Ramon Diaz-Arrastia4, Joshua W Gatson5. 1. Department of Neurological Surgery, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States. 2. Meso Scale Diagnostics, LLC., Rockville, MD 20850, United States. 3. Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States. 4. University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, United States. 5. Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States; Department of Neurological Surgery, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States. Electronic address: joshua.gatson@utsouthwestern.edu.
Abstract
INTRODUCTION: Each year in the United States, approximately 1.7 million people sustain a traumatic brain injury (TBI). Of these TBI events, about 75 percent are characterized as being mild brain injuries. Immediately following TBI, a secondary brain damage persists for hours, days, and even months. Previously, detection of neuronal and glial biomarkers have proven to be useful to predict neurological outcomes. Here, we hypothesized that creatine kinase, brain (CKBB) is a sensitive biomarker for acute secondary brain injury in professional boxers. METHODS: Blood (8cc) was collected from the boxing athletes (n=18) prior to and after competition (∼30min). The plasma levels of CKBB were measured using the Meso Scale Diagnostic (MSD) electrochemiluminescence (ECL) array-based multiplex format. Additional data such as number of blows to the head and symptom score (Rivermead Post Concussion Symptoms Questionnaire) were collected. RESULTS: At approximately 30min after the competition, the plasma levels of CKBB were significantly elevated in concussed professional boxers and correlated with the number of blows to the head and symptom scores. Additionally, receiver operating curve (ROC) analysis yielded a 77.8% sensitivity and a specificity of 82.4% with an area under the curve (AUC) of 90% for CKBB as an identifier of secondary brain injury within this population. CONCLUSION: This study describes the detection of CKBB as a brain biomarker to detect secondary brain injury in professional athletes that have experienced multiple high impact blows to the head. This acute biomarker may prove useful in monitoring secondary brain injury after injury.
INTRODUCTION: Each year in the United States, approximately 1.7 million people sustain a traumatic brain injury (TBI). Of these TBI events, about 75 percent are characterized as being mild brain injuries. Immediately following TBI, a secondary brain damage persists for hours, days, and even months. Previously, detection of neuronal and glial biomarkers have proven to be useful to predict neurological outcomes. Here, we hypothesized that creatine kinase, brain (CKBB) is a sensitive biomarker for acute secondary brain injury in professional boxers. METHODS: Blood (8cc) was collected from the boxing athletes (n=18) prior to and after competition (∼30min). The plasma levels of CKBB were measured using the Meso Scale Diagnostic (MSD) electrochemiluminescence (ECL) array-based multiplex format. Additional data such as number of blows to the head and symptom score (Rivermead Post Concussion Symptoms Questionnaire) were collected. RESULTS: At approximately 30min after the competition, the plasma levels of CKBB were significantly elevated in concussed professional boxers and correlated with the number of blows to the head and symptom scores. Additionally, receiver operating curve (ROC) analysis yielded a 77.8% sensitivity and a specificity of 82.4% with an area under the curve (AUC) of 90% for CKBB as an identifier of secondary brain injury within this population. CONCLUSION: This study describes the detection of CKBB as a brain biomarker to detect secondary brain injury in professional athletes that have experienced multiple high impact blows to the head. This acute biomarker may prove useful in monitoring secondary brain injury after injury.
Authors: Alex P Di Battista; Katherine A Moes; Maria Y Shiu; Michael G Hutchison; Nathan Churchill; Scott G Thomas; Shawn G Rhind Journal: Front Physiol Date: 2018-09-28 Impact factor: 4.566
Authors: Maximilian M Delsmann; Julian Stürznickel; Michael Amling; Peter Ueblacker; Tim Rolvien Journal: Orthopade Date: 2021-02-22 Impact factor: 1.087